A business in context
TVTX research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-09-15 | Heerma Peter | S · Sale | Common Stock | 27421.0 | 62.59 |
| 2026-09-15 | Heerma Peter | S · Sale | Common Stock | 71938.0 | 62.05 |
| 2026-09-15 | Heerma Peter | M · Exercise / conversion | Common Stock | 36526.0 | 8.93 |
| 2026-09-15 | Heerma Peter | M · Exercise / conversion | Common Stock | 1381.0 | 22.4 |
| 2026-09-15 | Heerma Peter | M · Exercise / conversion | Common Stock | 39283.0 | 26.88 |
| 2026-09-15 | Heerma Peter | M · Exercise / conversion | Employee stock option (right to buy) | 39283.0 | 0.0 |
| 2026-09-15 | Heerma Peter | M · Exercise / conversion | Employee stock option (right to buy) | 1381.0 | 0.0 |
| 2026-09-15 | Heerma Peter | M · Exercise / conversion | Employee stock option (right to buy) | 36526.0 | 0.0 |
| 2026-09-15 | Dube Eric M | M · Exercise / conversion | Common Stock | 95666.0 | 23.34 |
| 2026-09-15 | Dube Eric M | S · Sale | Common Stock | 63498.0 | 61.99 |
| 2026-09-15 | Dube Eric M | S · Sale | Common Stock | 28796.0 | 62.66 |
| 2026-09-15 | Dube Eric M | S · Sale | Common Stock | 3102.0 | 63.64 |
| 2026-09-15 | Dube Eric M | S · Sale | Common Stock | 270.0 | 65.31 |
| 2026-09-15 | Dube Eric M | M · Exercise / conversion | Employee stock option (right to buy) | 95666.0 | 0.0 |
| 2026-09-15 | ROTE WILLIAM E. | S · Sale | Common Stock | 63907.0 | 61.99 |
| 2026-09-15 | ROTE WILLIAM E. | S · Sale | Common Stock | 29021.0 | 62.66 |
| 2026-09-15 | ROTE WILLIAM E. | S · Sale | Common Stock | 3000.0 | 63.65 |
| 2026-09-15 | ROTE WILLIAM E. | S · Sale | Common Stock | 270.0 | 65.31 |
| 2026-09-15 | ROTE WILLIAM E. | M · Exercise / conversion | Common Stock | 39000.0 | 25.25 |
| 2026-09-15 | ROTE WILLIAM E. | M · Exercise / conversion | Common Stock | 39650.0 | 17.96 |
| 2026-09-15 | ROTE WILLIAM E. | M · Exercise / conversion | Employee stock option (right to buy) | 39000.0 | 0.0 |
| 2026-09-15 | ROTE WILLIAM E. | M · Exercise / conversion | Employee stock option (right to buy) | 39650.0 | 0.0 |
| 2026-09-15 | REED ELIZABETH E | S · Sale | Common Stock | 1400.0 | 63.69 |
| 2026-09-15 | REED ELIZABETH E | S · Sale | Common Stock | 300.0 | 65.31 |
| 2026-09-15 | REED ELIZABETH E | S · Sale | Common Stock | 13874.0 | 62.63 |
| 2026-09-15 | REED ELIZABETH E | S · Sale | Common Stock | 21926.0 | 62.03 |
| 2026-09-15 | REED ELIZABETH E | M · Exercise / conversion | Common Stock | 37500.0 | 15.46 |
| 2026-09-15 | REED ELIZABETH E | M · Exercise / conversion | Employee stock option (right to buy) | 37500.0 | 0.0 |
| 2026-09-10 | Meckler Jeffrey A | S · Sale | Common Stock | 3100.0 | 68.09 |
| 2026-09-10 | Meckler Jeffrey A | S · Sale | Common Stock | 14000.0 | 67.46 |
| 2026-09-10 | Meckler Jeffrey A | S · Sale | Common Stock | 1200.0 | 66.15 |
| 2026-09-10 | Meckler Jeffrey A | M · Exercise / conversion | Common Stock | 10000.0 | 26.52 |
| 2026-09-10 | Meckler Jeffrey A | M · Exercise / conversion | Common Stock | 10000.0 | 17.44 |
| 2026-09-10 | Meckler Jeffrey A | S · Sale | Common Stock | 1700.0 | 65.39 |
| 2026-09-10 | Meckler Jeffrey A | M · Exercise / conversion | Stock option (right to buy) | 10000.0 | 0.0 |
| 2026-09-10 | Meckler Jeffrey A | M · Exercise / conversion | Stock option (right to buy) | 10000.0 | 0.0 |
| 2026-09-02 | Cline Christopher R. | S · Sale | Common Stock | 642.0 | 66.37 |
| 2026-08-18 | LYONS GARY A | M · Exercise / conversion | Common Stock | 5000.0 | 17.44 |
| 2026-08-18 | LYONS GARY A | S · Sale | Common Stock | 900.0 | 63.86 |
| 2026-08-18 | LYONS GARY A | S · Sale | Common Stock | 4100.0 | 63.27 |
| 2026-08-18 | LYONS GARY A | M · Exercise / conversion | Stock option (right to buy) | 5000.0 | 0.0 |
| 2026-08-17 | LYONS GARY A | M · Exercise / conversion | Common Stock | 5000.0 | 17.44 |
| 2026-08-17 | LYONS GARY A | S · Sale | Common Stock | 1900.0 | 62.53 |
| 2026-08-17 | LYONS GARY A | S · Sale | Common Stock | 2600.0 | 63.5 |
| 2026-08-17 | LYONS GARY A | S · Sale | Common Stock | 500.0 | 64.16 |
| 2026-08-17 | LYONS GARY A | M · Exercise / conversion | Stock option (right to buy) | 5000.0 | 0.0 |
Identity & relationships
SEC issuer · 0001438533Travere Therapeutics, Inc.
Search names and former names
- Retrophin, Inc. · former SEC name · 2013-02-21 to 2020-11-13
- Desert Gateway, Inc. · former SEC name · 2008-06-27 to 2013-02-19
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $233.18M | $250.45M |
| 2023-12-31 | $145.24M | $160.59M |
| 2022-12-31 | $109.46M | $126.00M |
| 2021-12-31 | $131.84M | $163.91M |
| 2020-12-31 | $198.32M | $258.19M |
| 2019-12-31 | $175.34M | $231.07M |
| 2018-12-31 | $164.25M | $220.38M |
| 2017-12-31 | $154.94M | $212.97M |